North America leads with over 34% market share, while APAC shows a robust growth of 9.03%. Major players like Alcon, Carl Zeiss, and Johnson & Johnson drive innovation in advanced ocular devices ...

North America leads with over 34% market share, while APAC shows a robust growth of 9.03%. Major players like Alcon, Carl Zeiss, and Johnson & Johnson drive innovation in advanced ocular devices and ...

Patients exploring options for cataract surgery or Custom Lens Replacement now have access to one of the most advanced intraocular lenses available—the Bausch + Lomb enVista Envy lens—offered ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today launched “ Eyes Tell the Story: The Impact of Dry Eye ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter financial results on ...

Chris Bausch of Paso Robles City Council delayed releasing public records, sparking a lawsuit and raising concerns about transparency and accountability.

Bausch + Lomb and Walmart team up to offer free eye care clinics, samples, and education during Healthy Vision Month at 40 stores.

The recall of intraocular lenses is currently being wrapped up by Bausch + Lomb, after reports of inflammatory reactions following cataract surgery.

By Adriano Marchese Bausch + Lomb will return its enVista intraocular lenses to market following a voluntary recall in March after discovering they had certain production and material issues.

Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S ...

Bausch + Lomb (NYSE:BLCO – Get Free Report)‘s stock had its “equal weight” rating reissued by research analysts at Wells Fargo & Company in a research note issued to investors on Friday ...